1. Home
  2. USCB vs ABEO Comparison

USCB vs ABEO Comparison

Compare USCB & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USCB Financial Holdings Inc.

USCB

USCB Financial Holdings Inc.

HOLD

Current Price

$19.80

Market Cap

335.0M

Sector

Finance

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.56

Market Cap

307.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USCB
ABEO
Founded
2002
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
307.5M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
USCB
ABEO
Price
$19.80
$5.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$23.00
$20.00
AVG Volume (30 Days)
39.7K
918.3K
Earning Date
04-23-2026
05-13-2026
Dividend Yield
2.72%
N/A
EPS Growth
7.26
165.16
EPS
0.51
N/A
Revenue
N/A
$2,998,000.00
Revenue This Year
$26.46
$1,024.31
Revenue Next Year
$9.67
$145.42
P/E Ratio
$38.24
N/A
Revenue Growth
N/A
258.18
52 Week Low
$15.57
$4.00
52 Week High
$20.79
$7.54

Technical Indicators

Market Signals
Indicator
USCB
ABEO
Relative Strength Index (RSI) 64.17 51.58
Support Level $17.83 $5.24
Resistance Level $20.17 $5.64
Average True Range (ATR) 0.44 0.23
MACD 0.15 -0.02
Stochastic Oscillator 81.09 47.52

Price Performance

Historical Comparison
USCB
ABEO

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: